03/18/2024
6:00 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:33 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K/A | |
02/15/2024
3:42 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:43 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
STRATTAN CE RICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:44 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Toig Randall M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:45 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:46 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/15/2024
3:40 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
SHANAHAN WILLIAM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:41 PM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:44 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
01/22/2024
5:01 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
8:48 PM | Cross Shawn (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
8:50 PM | Cross Shawn (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
7:25 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:15 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
5:01 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
5:02 AM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
11/30/2023
3:29 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
3:30 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
11/30/2023
8:04 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
STRATTAN CE RICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Toig Randall M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
SHANAHAN WILLIAM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:07 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:08 AM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
11:15 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form EFFECT | |
11/21/2023
8:15 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/20/2023
7:50 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form S-4/A | |
11/14/2023
1:41 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
3:45 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
10/24/2023
3:43 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
Rafael Holdings, Inc. (Filed by)
| Form SC 13D/A | |
10/23/2023
5:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
FINE N SCOTT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
TATE JEFFREY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:07 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:08 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Rafael Holdings, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
1:19 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
10:45 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
10:46 AM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
09/21/2023
3:28 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
09/21/2023
3:28 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
2:35 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
Rafael Holdings, Inc. (Filed by)
| Form SC 13D/A | |
07/31/2023
1:16 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:01 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form DEF 14A | |
06/07/2023
7:46 PM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:22 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
